DexCom (DXCM)

Company

"DexCom, Inc., headquartered in San Diego, California, is a medical device company focused on the design, development, and commercialization of continuous glucose monitoring systems for people with diabetes." (company website)

DXCM 3-month stock chart

Buy

The steep slide that DexCom began in April moderated as months went on, and it looks like a bottom as been reached (see sidebar). The chart has shown strong improvement in the last few weeks, and the stock has pulled back 38% from the peak (Fibonacci numbers). I decided it's time to hop on for the ride.

  • Price momentum (PPO) — rapid acceleration, leveling off at a high level
  • Trend (ADX) — strong, with buying pressure (+DI) rising and selling pressure (-DI) falling
  • Money flow (CMF) — strong flow of money into the stock
  • Relative strength (RSI) — generally strong and strengthening
  • Volume — average volume near ½ million shares, higher than average was three months ago

Sell

loss Bottom line
-7%

After flirting with the 50-day moving average and the lower Bollinger band for several days, it looked like the DXCM pullback was over. Oops! For no apparent reason the stock fell more than 6% today, triggering my stop-loss order.